Pfizer (PFE) stock in focus as the company with Astellas Pharma (ALPMF) (ALPMY) announce a Phase 3 trial win for their ...

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...

Xtandi plus leuprolide improved overall survival in prostate cancer patients in the Phase 3 EMBARK trial, with no new safety ...

While the Japanese employee of Astellas Pharma was indicted in August last year, the Chinese side has not disclosed details ...

In July 2025, Novartis Pharmaceuticals conducted a Phase III multi-center, single dose (1.2 x 1014 vector genomes), ...

View today's Astellas Pharma Inc. stock price and latest 4503 news and analysis. Create real-time notifications to follow any changes in the live stock price.

View the latest Astellas Pharma Inc. ADR (ALPMY) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Review quarterly and annual revenue, net income, and cash flow for Astellas Pharma Inc (ALPMF:PINX) stock through the last fiscal year.

Astellas Pharma has bought bioelectronic medical devices firm iota Biosciences in a deal worth up to $429m, building on a previous research partnership.

Get the detailed quarterly/annual income statement for Astellas Pharma Inc. (ALPMY). Find out the revenue, expenses and profit or loss over the last fiscal year.

During the menopause transition, only 1 in 5 women have optimal scores using the American Heart Association’s health-assessment tool, known as Life’s Essential 8 (LE8). Among the tool’s eight ...